Cargando…

HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control

Intense research activity in HPV modelling over this decade has prompted the development of additional guidelines to those for general modelling. A specific framework is required to address different policy questions and unique complexities of HPV modelling. HPV-FRAME is an initiative to develop a c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Canfell, Karen, Kim, Jane J., Kulasingam, Shalini, Berkhof, Johannes, Barnabas, Ruanne, Bogaards, Johannes A., Campos, Nicole, Jennett, Chloe, Sharma, Monisha, Simms, Kate T., Smith, Megan A., Velentzis, Louiza S., Brisson, Marc, Jit, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804684/ https://www.ncbi.nlm.nih.gov/pubmed/31505258 http://dx.doi.org/10.1016/j.pvr.2019.100184

Ejemplares similares

Pricing of HPV vaccines in European tender-based settings
por: Qendri, Venetia, et al.
Publicado: (2018)

Who Will Benefit From Expanding HPV Vaccination Programs to Boys?
por: Qendri, Venetia, et al.
Publicado: (2018)

A modelled analysis of the impact of COVID-19-related disruptions to HPV vaccination
por: Velentzis, Louiza S, et al.
Publicado: (2023)

Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts
por: Jit, Mark, et al.
Publicado: (2013)

The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: A modelling study
por: Hall, Michaela T., et al.
Publicado: (2020)

Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer ≥15 years later
por: Inturrisi, Federica, et al.
Publicado: (2022)

Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening
por: Velentzis, Louiza S., et al.
Publicado: (2023)

Vaccine Effectiveness Following Routine Immunization With Bivalent Human Papillomavirus (HPV) Vaccine: Protection Against Incident Genital HPV Infections From a Reduced-Dosing Schedule
por: Hoes, Joske, et al.
Publicado: (2021)

Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
por: Saville, Marion, et al.
Publicado: (2019)

Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations
por: Velentzis, Louiza S., et al.
Publicado: (2017)

Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence
por: Arbyn, Marc, et al.
Publicado: (2020)

Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia
por: Hall, Michaela T., et al.
Publicado: (2018)

Menopausal hormone therapy: Characterising users in an Australian national cross-sectional study
por: Velentzis, Louiza S., et al.
Publicado: (2021)

Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
por: Bogaards, Johannes A, et al.
Publicado: (2019)

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial
por: Canfell, Karen, et al.
Publicado: (2017)

4223 Changes in positive predictive value of cervical cytology following HPV vaccination
por: Teoh, Deanna, et al.
Publicado: (2020)

Projected impact of HPV vaccination and primary HPV screening on cervical adenocarcinoma: Example from Australia
por: Smith, Megan A., et al.
Publicado: (2017)

Progress in eliminating HPV-associated disease
por: Stern, Peter L., et al.
Publicado: (2019)

IPVS Policy statement on safety of HPV vaccines
por: .
Publicado: (2015)

HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test
por: Polman, Nicole J, et al.
Publicado: (2017)

Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand
por: Lew, Jie-Bin, et al.
Publicado: (2016)

HPV vaccination in Kenya: a study protocol to assess stakeholders' perspectives on implementation drivers of HPV vaccination and the acceptability of the reduced dose strategy among providers
por: Umutesi, Grace, et al.
Publicado: (2023)

Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling Analyses
por: Barnabas, Ruanne V, et al.
Publicado: (2006)

Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping
por: Dick, Stèfanie, et al.
Publicado: (2021)

A review of HPV and HBV vaccine hesitancy, intention, and uptake in the era of social media and COVID-19
por: Vraga, Emily K, et al.
Publicado: (2023)

Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis
por: Staadegaard, Lisa, et al.
Publicado: (2022)

Risk of cervical precancer among HPV–negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a randomized screening study
por: Inturrisi, Federica, et al.
Publicado: (2022)

Ability of epidemiological studies to monitor HPV post-vaccination dynamics: a simulation study
por: Bonneault, Mélanie, et al.
Publicado: (2023)

Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study
por: Velentzis, Louiza S., et al.
Publicado: (2016)

Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis
por: Kulasingam, Shalini L, et al.
Publicado: (2008)

Potential effectiveness of prophylactic HPV immunization for men who have sex with men in the Netherlands: A multi-model approach
por: Bogaards, Johannes A., et al.
Publicado: (2019)

Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use
por: Smith, Megan A., et al.
Publicado: (2016)

Challenges related to human papillomavirus (HPV) vaccine uptake in Minnesota: clinician and stakeholder perspectives
por: Yared, Nicholas, et al.
Publicado: (2021)

Incremental Benefits of Male HPV Vaccination: Accounting for Inequality in Population Uptake
por: Smith, Megan A., et al.
Publicado: (2014)

An exploration of individual- and population-level impact of the 2-dose HPV vaccination schedule in pre-adolescent girls
por: Donken, Robine, et al.
Publicado: (2016)

IPVS Policy Statement addressing the burden of HPV disease for Indigenous peoples
por: Lawton, Beverley, et al.
Publicado: (2019)

Evolution and Taxonomic Classification of Alphapapillomavirus 7 Complete Genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70
por: Chen, Zigui, et al.
Publicado: (2013)

Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67
por: Chen, Zigui, et al.
Publicado: (2011)

Evidence for Missing Positive Results for Human Papilloma Virus 45 (HPV-45) and HPV-59 with the SPF(10)-DEIA-LiPA(25) (Version 1) Platform Compared to Type-Specific Real-Time Quantitative PCR Assays and Impact on Vaccine Effectiveness Estimates
por: van Eer, Kahren, et al.
Publicado: (2020)

Framing of national HPV vaccine recommendations and willingness to recommend at ages 9-10
por: Kahn, Benjamin Z., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rd6fjaa5a37vvdo0i5rebjfdu0